Burgdorf – Ypsomed (SIX: YPSN) is on track and achieved consolidated sales of CHF 244.2 million in the first half of the 2022/23 financial year (previous year: CHF 222.6 million). This corresponds to a growth of 9.7% compared with the previous year. At constant currency rates compared to the previous year, this would have represented an increase of around 13%. With this growth, the company has significantly increased its operating profit (EBIT) from CHF 10.5 million to CHF 19.4 million and doubled its net profits to CHF 15.4 million (previous year CHF 7.1 million). Despite a challenging general environment, Ypsomed confirms its positive assessment of future business development and its outlook.
Read more … Ypsomed doubles profits and confirms outlook